Physician profile
Hyatt D Sutton
NPI 1699760587
$8,828.47
in general payments reported to CMS, 2019-2025
39 companies · $1,732 in 2025
The $1,732 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $671 · 2021: $830 · 2022: $1,263 · 2023: $2,208 · 2024: $1,521 · 2025: $1,732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,460.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,678.29 | 2019-2025 | |
| Amgen INC. | $1,169.64 | 2019-2025 | Otezla, Repatha, Evenity |
| Novo Nordisk INC | $815.34 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $685.25 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $659.61 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $528.28 | 2022-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $307.58 | 2019-2025 | |
| Abbvie INC. | $279.42 | 2021-2025 | Ubrelvy |
| Glaxosmithkline, LLC. | $267.65 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $240.12 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $236.76 | 2020-2024 | Spravato, Xarelto |
| Antares Pharma, INC. | $223.62 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $207.51 | 2022-2025 | Veozah, Myrbetriq |
| Kowa Pharmaceuticals America, INC. | $166.83 | 2022-2025 | Livalo, Zoryve, Seglentis |
| Phathom Pharmaceuticals, INC. | $133.97 | 2024-2025 | Voquezna |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyatt Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.